Next Article in Journal
Brachytherapy Approach Using 177Lu Conjugated Gold Nanostars and Evaluation of Biodistribution, Tumor Retention, Dosimetry and Therapeutic Efficacy in Head and Neck Tumor Model
Next Article in Special Issue
Neuroinflammation as a Therapeutic Target in Retinitis Pigmentosa and Quercetin as Its Potential Modulator
Previous Article in Journal
miRNA Delivery by Nanosystems: State of the Art and Perspectives
Previous Article in Special Issue
Artepillin C Reduces Allergic Airway Inflammation by Induction of Monocytic Myeloid-Derived Suppressor Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 13
Issue 11
10.3390/pharmaceutics13111902
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Use of Menthol in Skin Wound Healing—Anti-Inflammatory Potential, Antioxidant Defense System Stimulation and Increased Epithelialization

by
Ariane Leite Rozza
1,*,
Fernando Pereira Beserra
1,
Ana Júlia Vieira
1,
Eduardo Oliveira de Souza
1,
Carlos Alberto Hussni
2,
Emanuel Ricardo Monteiro Martinez
1,
Rafael Henrique Nóbrega
1 and
Cláudia Helena Pellizzon
1
1
Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Dr. Antonio Celso W Zanin Street, 250, Botucatu 18618-689, Brazil
2
Department of Surgery and Veterinary Anesthesiology, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Dr. Walter M Correa Street, Botucatu 18618-689, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceutics 2021, 13(11), 1902; https://doi.org/10.3390/pharmaceutics13111902
Submission received: 22 September 2021 / Revised: 2 November 2021 / Accepted: 3 November 2021 / Published: 9 November 2021
(This article belongs to the Special Issue Anti-inflammatory Effects from Natural Bioactive Compounds—from Bench to Bedside)
Browse Figures
Versions Notes

Abstract

:
Wound healing involves inflammatory, proliferative, and remodeling phases, in which various cells and chemical intermediates are involved. This study aimed to investigate the skin wound healing potential of menthol, as well as the mechanisms involved in its effect, after 3, 7, or 14 days of treatment, according to the phases of wound healing. Skin wound was performed in the back of Wistar rats, which were topically treated with vehicle cream; collagenase-based cream (1.2 U/g); or menthol-based cream at 0.25%, 0.5%, or 1.0% over 3, 7, or 14 days. Menthol cream at 0.5% accelerated the healing right from the inflammatory phase (3 days) by decreasing mRNA expression of inflammatory cytokines TNF-α and Il-6. At the proliferative phase (7 days), menthol 0.5% increased the activity of antioxidant enzymes SOD, GR, and GPx, as well as the level of GSH, in addition to decreasing the levels of inflammatory cytokines TNF-α, IL-6, and IL-1β and augmenting mRNA expression for Ki-67, a marker of cellular proliferation. At the remodeling phase (14 days), levels of inflammatory cytokines were decreased, and the level of Il-10 and its mRNA expression were increased in the menthol 0.5% group. Menthol presented skin wound healing activity by modulating the antioxidant system of the cells and the inflammatory response, in addition to stimulating epithelialization.

Graphical Abstract

1. Introduction

Skin wound healing involves an array of biochemical, molecular, cellular, and tissue processes [1]. The physiological events that lead to wound repair can be divided into three dynamic phases: inflammatory, proliferative, and tissue remodeling. These overlapping steps encompass a network of cellular communication that ensures the progress of the healing process [2].
Hemostasis and inflammation occur immediately after the tissue damage. Hemostasis is assisted by the formation of a fibrin hemostatic plug, preventing the bleeding. The prevention of infection is a process orchestrated by the inflammatory cells. Neutrophils and macrophages make phagocytosis of pathogens and tissue debris, as well as secret growth factors and cytokines, essential signaling molecules for triggering the proliferative phase [3,4].
The development of granulation tissue is the peculiarity of the proliferative phase. The proliferation of epithelial cells constitutes the new epidermis in a process named epithelialization. The contraction of myofibroblasts approximates the wound edges, reducing the wound area. Many kinds of cytokines and growth factors play an essential role in skin wound repair [5].
The last stage of wound repair is the extracellular matrix remodeling, in which the apoptosis of macrophages and myofibroblasts occur, ending the formation of the granulation tissue. The type III collagen is replaced with type I collagen in a process that can last for months [6].
The treatment of skin wounds is responsible for the largest investment in research and development among all skin diseases [7] and is among the most critical issues in medical science [5]. Clinically, several drugs have been developed, aiming to accelerate the wound healing process but presenting side effects or low efficiency. In modern medical sciences, searching for drugs that accelerate wound healing with minimal pain, discomfort, and scarring is a promising area of research [6]. Several studies have successfully tested the effects of medicinal plants in skin wound healing, in which the extracts or their isolated compounds accelerated skin wound closure, inhibited local inflammation, and increased cellular antioxidant defense [8,9]. Plant-based therapy is known to accelerate wound healing as well as maintaining the aesthetics in a natural way [10]; this is the reason why more than 70% of wound healing pharmaceutical products are derived from plants [11].
Menthol is a monocyclic monoterpene found in the essential oil of some species of the genus Mentha [12]. Menthol is an agonist of transient receptor potential melastatin-8 channels, cold receptors in the sensory nerves of the skin. For this reason, menthol exerts a cooling sensation when applied to the skin and mucosal membranes [13]. The activation of TRPM8 channels does not influence skin wound healing [14]. Menthol also activates TRPV3 channels and presents a bimodal effect in TRPA1 and TRPV1 [15]. Some studies have shown that the activation of TRPV3 channels contributes to wound healing in the skin [16], oral mucosa [17], and corneal epithelial cells [18]. Furthermore, the inhibition of TRPA1 and TRPV1 channels is involved with the pain-relieving effect of menthol [19]. Menthol is widely used in cosmetics, as well as in the medicinal preparations for the relief of pain [20] and respiratory conditions [21].
Previous studies have shown that menthol has antinociceptive [22], antimicrobial [23], and antiulcerogenic properties [24,25]. We hypothesized that these biological effects could make menthol a promising molecule to be used in wound healing, and in this study, we aimed to investigate the potential of menthol in skin wound healing in Wistar rats, as well as to assess biochemical and molecular parameters involved in the effect, at the three phases of wound healing.

2. Material and Methods

2.1. Animals

Male Wistar rats (200–250 g, 8 to 10 weeks old) were acquired from Central Animal House of UNESP Botucatu. The rats were housed in cages for acclimatization with temperature (21 ± 2 °C) and humidity (60 ± 1%) controlled with 12 h light/dark cycles. The rats were fed a certified diet. All efforts were made to avoid animal suffering. The researchers followed the guidelines of the Canadian Council on Animal Care. The experimental protocols were approved by the Institutional Animal Care and Use Committee (protocol 793-CEUA).

2.2. Development of Creams Used in Skin Wound Treatment

(−)-Menthol (<99% purity) was purchased from Merck and incorporated into Lanette cream at concentrations of 0.25% (ME0.25), 0.5% (ME0.5), and 1% (ME1.0). Collagenase was incorporated into Lanette cream and used as a reference drug (1.2 U/g). Lanette cream alone was used as the vehicle group.

2.3. Skin Wound Procedure and Treatment

At first, the rats were anesthetized using an intraperitoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg), before a single subcutaneous injection of ketoprofen (100 mg/kg) to alleviate postoperative discomfort. The back of the rats was previously trichotomized, and a skin wound was performed using a punch with 2 cm of diameter. After the wounding procedure, the rats were moved to individual cages and randomly distributed into six groups of treatment (n = 8): vehicle (Lanette cream), collagenase-based cream (1.2 U/g), or three crescent concentrations of menthol-based cream (ME.025, ME0.5, or ME1.0). Once a day, the wound region was measured by planimetry and photographed using a ruler as a scale, and the creams were applied in the skin wounds. The rats were treated over 3, 7, or 14 days, according to the phases of wound healing (inflammatory, proliferative, and tissue remodeling phase) [26]. At the end of each period, the rats were euthanized by deepening the anesthetic plan. The wound region was collected to perform histological, biochemical, and molecular assays; livers were also collected to perform antioxidant assays. The samples were preserved at −80 °C or destined to histological analysis.

2.4. Wound Area Contraction Rate

The wound area was calculated using Adobe Photoshop CS3, according to the following equation: (wound area at day one—wound area at the day 3, 7 or 14/wound area at day 1) × 100. The result was expressed as the percentage of wound contraction [27].

2.5. Histological Analysis

Skin samples were fixed, embedded in paraffin, cut to a thickness of 5 µm, and stained with hematoxylin and eosin (HE) for histological evaluation. Photomicrographs were taken using a camera attached to the microscope.

2.6. Analysis of Antioxidant and Myeloperoxidase (MPO) Activities

These assays were performed in the liver [28]. The superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GR) activities were evaluated according to Winterbourn et al. [29], Yoshikawa et al. [30], and Carlberg and Mannervick [31], respectively. The glutathione (GSH) levels were measured [32]. MPO activity was measured to assess the neutrophils activation [33].

2.7. Analysis of Anti-Inflammatory Activity

Skin samples were diluted in phosphate buffered saline and centrifuged at 4 °C; then, the level of cytokines was measured using enzyme-linked immunosorbent assay (ELISA) kits for interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) from R&D Systems, following the manufacturer’s instructions.

2.8. Analysis by Real-Time Quantitative Gene Expression: RT-qPCR

The total skin RNA was extracted and treated to avoid DNA contamination, and subsequently, cDNA synthesis was performed [34]. For qPCR, Cq values were determined using a SYBR Green kit (Invitrogen, Carlsbad, CA, USA), the gene Ef-1α was used as a reference, and subsequently the values were calibrated with ddCT. qPCR reactions (20 µL) used 900 nM for each primer and 700 ng of total RNA. The reactions were performed in duplicate, according to the manufacturer’s protocol, and relative gene expression profiles were calculated [35]. qPCR was conducted using designed and specific primers for Rattus norvegicus (Table 1).

2.9. Statistical Analysis

The results were analyzed using one-way ANOVA followed by Dunnett’s test. The results were presented as the mean ± s.e.m., and statistical significance was set at p < 0.05. All analyses were performed using Graph Pad Prism.

3. Results

3.1. Skin Wounds Healing

We used an excisional wound model for investigating the influence of menthol on the healing process in rats. The sequence of wound healing can be assessed by daily monitoring of the wound contraction [36]. At day 3, only the rats treated with ME0.5 presented a significant percentage of wound contraction (11%, p < 0.05) in comparison to the vehicle group. Rats treated with ME0.25, ME1.0, or collagenase cream presented similar wound contraction when compared to the vehicle group (Figure 1). At the end of 7 days of treatment, all groups treated with menthol presented higher percentage of wound contraction in comparison to the vehicle group. Respectively, the percentage of wound closure was 53%, 58%, and 54% for ME0.25, ME0.5 and ME1.0 (p < 0.05, p < 0.01, and p < 0.05; Figure 1). Finally, after 14 days of treatment, the group treated with ME0.5 maintained a higher percentage of wound closure (87%, p < 0.05), indicating that the healing process in this group was accelerated during all the treatment period. The other groups presented wound contraction percentage similar to the vehicle group (Figure 1). Since menthol-based cream at the concentration of 0.5% was the effective concentration in the three periods tested, we used the samples of this group for all subsequent analyses.
Regarding the appearance of the wounds, in the first three days, we observed redness, inflammation, and swelling in all groups, which could explain the decrease in wound contraction (except for ME0.5) observed in Figure 1. Such characteristics were gradually disappearing and giving rise to the granulation tissue, indicating the onset of the proliferative phase. This process can be seen in Figure 2.

3.2. Histological Analysis

At day 3, there was an intense inflammatory infiltrate in the wound region and in the dermis. At day 7, the granulation tissue formed in the menthol-treated group recovered a normal epithelium, which could be seen in the margin of the wound, an effect that was more pronounced after 14 days of treatment, when the reestablishment of the epidermis on the wound margins occurred, growing towards the center. In the dermis, there were cells of the connective tissue (mainly fibroblasts) and deposition of collagen fibers, demonstrating effective extracellular matrix remodeling (Figure 3).

3.3. MPO and Antioxidant Activities

SOD, GPx, and GR activities were measured, in addition to the quantity of GSH. Such enzymes and protein scavengers free radicals and prevent oxidative damage. The effectiveness of the wound healing process is directly related to the antioxidant ability of the therapeutic agent, since removing free radicals significantly accelerates the healing process, reducing tissue damage and wound infection [9,37]. The activity of MPO was also measured as an indicator of pro-oxidant and pro-inflammatory activity. After three days of treatment, ME0.5 was not able to induce alterations in the activity or quantity of the measured parameters. However, at day 7, all antioxidative parameters were increased (activities of GR, GPx, and SOD, and the level of GSH), and the activity of MPO was not altered. After 14 days of treatment, the antioxidative parameters were normalized, and the activity of MPO was decreased (Table 2).

3.4. Anti-Inflammatory Activity

Cytokines are messenger molecules of the immune system that perform the interaction between immune, nervous, and endocrine systems; several cytokines are involved in the skin wound healing process [38]. After three days of treatment, the levels of cytokines were not different among groups. At day 7, the treatment with ME0.5 was able to decrease inflammatory cytokine production, which persisted until day 14, when the levels of IL-10 were increased (Table 3).

3.5. Gene Expression

At day 3, mRNA expression for Il-1β, TNF-α, and Il-10 was decreased in the ME0.5 group (Figure 4A–C). After seven days of treatment, the mRNA expression of TNF-α was decreased, which persisted until day 14 (Figure 4B), when mRNA expression of Il-10 was increased (Figure 4C). After 7 and 14 days of treatment, the mRNA expression of Ki-67 was augmented in this group (Figure 4D), which could indicate cell proliferation activity to recover the wounded area.

4. Discussion

Modaressi et al. [39] showed that the topical application of Mentha piperita ointment at 4% and 8% accelerated the healing of infected skin wounds in mice after 4, 8, 12, and 16 days of treatment. The authors attributed the effect mainly to the modulation of the mRNA expression of the inflammation-related genes by menthol. Babamohamadi et al. [40] evidenced that a Mentha piperita gel (applied three times a day up to 14 days) prevented the development of pressure ulcers in hospitalized patients. In this study, we intended to prospect the effect of menthol in skin wound healing. Skin wounds were developed in rats and treated with menthol-based creams for 3, 7, or 14 days, according to previously described stages of wound healing: inflammatory, proliferative, and tissue remodeling phase [9]. This is the first study evaluating the in vivo wound healing potential of menthol, and we have demonstrated that, topically applied, menthol at the concentration of 0.5% accelerated the wound closure in 3, 7, and 14 days of treatment. The mechanisms potentially involved in the effect are discussed as follows.
Several studies have demonstrated that, at the site of skin wounds, the concentration of reactive oxygen species (ROS) increases and antioxidant production decreases, leading to a delayed wound healing [41]. Therefore, compounds with antioxidant potential are good therapeutic agents for accelerating the wound healing process [42]. In the inflammatory phase, neutrophils and macrophages produce large amounts of ROS, which directly attack pathogens but also damage the healthy surrounding tissues. Superoxide anions are dismutated to H2O2 and oxygen by SOD. Subsequently, H2O2 is detoxified by peroxidases such as GPX, preventing the generation of hydroxyl radicals, the most harmful forms of ROS, requiring GSH as an electron donor. Such antioxidant enzymes are abundantly present in the skin and are crucial to scavenging ROS during wound healing [43]. GSH is a non-enzymatic antioxidant converted to inactive form after reacting with ROS. Its levels are decreased in cutaneous wounds in comparison to healthy skin. The inhibition of ROS production triggers angiogenesis and fibroblast proliferation, stimulating the skin wound closure. MPO is an oxidant and inflammatory enzyme released by neutrophils. Excessive neutrophils in the wound site trigger excessive ROS production by MPO, delaying the wound healing [44]. We demonstrated that, in the inflammatory phase, topical treatment with menthol 0.5% did not alter the systemic activities of GR, GPx, SOD, and MPO, nor the level of GSH. However, in the proliferative phase, menthol increased the activities of GR, GPx, and SOD, as well as the level of GSH, evidencing an antioxidant effect at this phase. At the tissue remodeling phase, menthol decreased MPO activity; the enzyme activity and GSH level were normalized. We hypothesized that the cells produced at the proliferative phase helped to increase the production of antioxidant molecules in an effect that was normalized after 14 days of treatment (tissue remodeling phase).
During wound healing, monocytes arrive at the wound site and turn into macrophages, releasing several inflammatory mediators and cytokines, and producing ROS. TNF-α, IL-1β, and IL-6 are inflammatory cytokines that play significant roles in the inflammatory process during skin wound healing because they coordinate actions of different types of cells [38]. Secreted cytokines induce chemokines of chemotaxis, attracting immune cell to the site of the injury, contributing to skin repair and homeostasis [45]. We did not find alterations in cytokine levels induced by menthol after 3 days of treatment, suggesting that the treatment did not inhibit the inflammatory phase. However, at proliferative and extracellular matrix remodeling phases, menthol decreased the levels of TNF-α, IL-6, and IL-1β. In addition, at the remodeling phase, menthol treatment increased the activity of IL-10, which dampens the expression of pro-inflammatory cytokines, as well as anti-scarring function [3]. Our results are in accordance with several studies reported in the literature. Such studies showed that the inflammatory phase restores homeostasis, and that, in the proliferative phase, fibroblasts and other cells from the connective tissue infiltrate the wound site and secrete cytokines, attracting keratinocytes and leading to re-epithelialization [26,46]. Preventing prolonged inflammation by suppressing the production of inflammatory cytokines is a desirable target for wound healing products; excessive inflammation results in chronic wounds and scar formation [47]. The modulation of cytokines production by menthol denotes an anti-inflammatory activity, which is confirmed in the literature using different animal models [48,49].
Epithelialization has a key role in wound healing, especially at the proliferative phase, and is used as an index of its success [50]. We observed a variable correlation between the relative mRNA expression and the levels of cytokines obtained by ELISA method, which leads us to suppose that menthol acts through a post-transcriptional or/and post-translational regulation; however, it also can be credited by differences in mRNA and proteins half-lives [51]. The mRNA expression levels of TNF-α and Il-10 in the vehicle group are in accordance with the results obtained by Kubo et al. [52], who investigated the temporal expression of wound healing-related genes after skin injury. Tatiya-Aphiradee et al. [53], Luo et al. [54], and Ram et al. [55] also found similar results for the mRNA expression level of TNF-α after the treatment of skin wounds with natural products. The increased mRNA expression for Ki-67 at the proliferative phase in menthol-treated rats indicates enhanced epithelialization, resulting in a better quality of the granulation tissue and the diminishing of the wound surface [56].

5. Conclusions

We reported for the first time that menthol accelerates skin wound healing through several mechanisms. At the inflammatory phase, menthol decreased mRNA expression of inflammatory cytokines. At the proliferative phase, menthol displayed antioxidant and anti-inflammatory activities, in addition to stimulating cell proliferation, contributing to the formation of granulation tissue. At the last phase (tissue remodeling), menthol reinforced its anti-inflammatory activity by increasing the mRNA expression and the production of IL-10, as well as decreasing the levels of inflammatory cytokines and MPO activity. To our knowledge, this is the first study about skin wound healing activity from menthol, and these innovative findings could enable this compound as a potential substance to be used in skin wound healing.

Author Contributions

Conceptualization, A.L.R. and F.P.B.; methodology, A.L.R., F.P.B., A.J.V. and E.O.d.S.; validation, E.R.M.M.; formal analysis, A.L.R., F.P.B., A.J.V. and E.R.M.M.; investigation, A.L.R., F.P.B., A.J.V., E.O.d.S. and C.A.H.; resources, A.L.R., R.H.N. and C.H.P.; data curation, F.P.B., A.J.V., E.O.d.S. and E.R.M.M.; writing—original draft preparation, A.L.R. and A.J.V.; writing—review and editing, E.R.M.M., R.H.N., and C.H.P.; visualization, A.L.R., A.J.V., E.O.d.S. and E.R.M.M.; supervision, A.L.R., R.H.N. and C.H.P.; project administration, A.L.R., R.H.N. and C.H.P.; funding acquisition, A.L.R. and C.H.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), grant numbers 2013/22202-4, 2013/23340-1, 2015/06636-0, and 2016/13307-5; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), grant number 406854/2016-5; and Pró-Reitoria de Pesquisa (PROPE/Unesp).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Institute of Biosciences, São Paulo State University (protocol code 793).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be provided upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Goswami, S.; Kandhare, A.; Zanwar, A.A.; Hegde, M.V.; Bodhankar, S.L.; Shinde, S.; Deshmukh, S.; Kharat, R. Oral L-glutamine administration attenuated cutaneous wound healing in Wistar rats. Int. Wound J. 2019, 13, 116–124. [Google Scholar] [CrossRef]
  2. Laberge, A.; Arif, S.; Moulin, V.J. Microvesicles: Intercellular messengers in cutaneous wound healing. J. Cell Physiol. 2018, 233, 5550–5563. [Google Scholar] [CrossRef]
  3. Profyris, C.; Tziotzios, C.; Do Vale, I. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J. Am. Acad. Dermatol. 2012, 66, 1–10. [Google Scholar] [CrossRef]
  4. Pang, Y.; Zhang, Y.; Huang, L.; Xu, L.; Wang, K.; Wang, D.; Guan, L.; Zhang, Y.; Yu, F.; Chen, Z.; et al. Effects and Mechanisms of Total Flavonoids from Blumea balsamifera (L.) DC. on Skin Wound in Rats. Int. J. Mol. Sci. 2017, 18, 2766. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Hemmati, A.A.; Larki-Harchegani, A.; Shabib, S.; Jalali, A.; Rezaei, A.; Housmand, G. Wound healing property of milk in full thickness wound model of rabbit. Int. J. Surg. 2018, 54, 133–140. [Google Scholar] [CrossRef] [PubMed]
  6. Kandhare, A.D.; Alam, J.; Patil, M.V.; Sinha, A.; Bodhankar, S.L. Wound healing potential of naringin ointment formulation via regulating the expression of inflammatory, apoptotic and growth mediators in experimental rats. Pharm. Biol. 2016, 54, 419–432. [Google Scholar] [CrossRef]
  7. Zeng, R.; Lin, C.; Lin, Z.; Chen, H.; Lu, W.; Lin, C.; Li, H. Approaches to cutaneous wound healing: Basics and future directions. Cell Tissue Res. 2018, 374, 217–232. [Google Scholar] [CrossRef]
  8. Öz, B.E.; İşcan, G.S.; Akkol, E.K.; Süntar, İ.; Acıkara, Ö.B. Isofavonoids as wound healing agents from Ononidis radix. J. Ethnopharmacol. 2018, 211, 384–393. [Google Scholar] [CrossRef]
  9. Rodrigues, R.O.; Yaochite, J.N.U.; Sasahara, G.L.; Albuquerque, A.A.; Fonseca, S.G.C.; Araújo, T.D.V.; Santiago, G.M.P.; de Sousa, L.M.; de Carvalho, J.L.; Alves, A.P.N.N.; et al. Antioxidant, anti-inflammatory and healing potential of ethyl acetate fraction of Bauhinia ungulata L. (Fabaceae) on in vitro and in vivo wound model. Mol. Biol. Rep. 2020, 47, 2845–2859. [Google Scholar] [CrossRef] [PubMed]
  10. Ahmed, R.R.; Aboud, E. Quercetin and low level laser therapy promote wound healing process in diabetic rats via structural reorganization and modulatory effects on inflammation and oxidative stress. Biomed. Pharm. 2018, 101, 58–73. [Google Scholar] [CrossRef] [PubMed]
  11. Aruna, S.M.; Sravanthi, V.; Sri, U.J.; Priya, N.S.; Rama, R.N. An overview of herbs possessing wound healing activity. Eur. J. Pharm Med. Res. 2015, 7, 329–332. [Google Scholar]
  12. Croteau, R.B.; Davis, E.M.; Ringer, K.L.; Wildung, M.R. (−)-Menthol biosynthesis and molecular genetics. Naturwissenschaften 2005, 92, 562–577. [Google Scholar] [CrossRef] [PubMed]
  13. Limpanuparb, T.; Lorpaiboon, W.; Chinsukserm, K. An in silico investigation of menthol metabolism. PLoS ONE 2019, 14, e0216577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Isman, E.; Aras, M.H.; Cengiz, B.; Bayraktar, R.; Yolcu, U.; Topcuoglu, T.; Usumez, A.; Demir, T. Effects of laser irradiation at different wavelengths (660, 810, 980, and 1064 nm) on transient receptor potential melastatin channels in an animal model of wound healing. Lasers Med. Sci. 2015, 30, 1489–1495. [Google Scholar] [CrossRef]
  15. Nguyen, T.H.D.; Itoh, S.G.; Okumura, H.; Tominaga, M. Structural basis for promiscuous action of monoterpenes on TRP channels. Commun. Biol. 2021, 4, 293. [Google Scholar] [CrossRef]
  16. Miyamoto, T.; Petrus, M.J.; Dubin, A.E.; Patapoutian, A. TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin. Nat. Commun. 2011, 2, 369. [Google Scholar] [CrossRef]
  17. Aijima, R.; Wang, B.; Takao, T.; Mihara, H.; Kashio, M.; Ohsaki, Y.; Zhang, J.Q.; Mizuno, A.; Suzuki, M.; Yamashita, Y.; et al. The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia. FASEB J. 2015, 29, 182–192. [Google Scholar] [CrossRef]
  18. Yamada, T.; Ueda, T.; Ugawa, S.; Ishida, Y.; Imayasu, M.; Koyama, S.; Shimada, S. Functional expression of transient receptor potential vanilloid 3 (TRPV3) in corneal epithelial cells: Involvement in thermosensation and wound healing. Exp. Eye Res. 2010, 90, 121–129. [Google Scholar] [CrossRef]
  19. Xu, H.; Blair, N.T.; Clapham, D.E. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J. Neurosci. 2005, 25, 8924–8937. [Google Scholar] [CrossRef] [Green Version]
  20. Liu, B.; Fan, L.; Balakrishna, S.; Sui, A.; Morris, J.B.; Jordt, S.E. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain 2013, 154, 2169–2177. [Google Scholar] [CrossRef] [Green Version]
  21. Patel, T.; Ishiuji, Y.; Yosipovitch, G. Menthol: A refreshing look at this ancient compound. J. Am. Acad. Derm. 2007, 57, 873–878. [Google Scholar] [CrossRef]
  22. Haeseler, G.; Maue, D.; Grosskreutz, J.; Bufler, J.; Nentwig, B.; Piepenbrock, S.; Dengler, R.; Leuwer, M. Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. Eur. J. Anaesthesiol. 2002, 19, 571–579. [Google Scholar] [CrossRef] [PubMed]
  23. Işcan, G.; Kirimer, N.; Kürkcüoğlu, M.; Başer, K.H.; Demirci, F. Antimicrobial screening of Mentha piperita essential oils. J. Agric. Food Chem. 2002, 50, 3943–3946. [Google Scholar] [CrossRef]
  24. Rozza, A.L.; Hiruma-Lima, C.A.; Takahira, R.K.; Padovani, C.R.; Pellizzon, C.H. Effect of menthol in experimentally induced ulcers: Pathways of gastroprotection. Chem-Biol. Interact. 2013, 206, 272–278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Rozza, A.L.; Meira de Faria, F.; Souza Brito, A.R.; Pellizzon, C.H. The gastroprotective effect of menthol: Involvement of anti-apoptotic, antioxidant and anti-inflammatory activities. PLoS ONE 2014, 9, e86686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Gurtner, G.C.; Werner, S.; Barrandon, Y.; Longaker, M.T. Wound repair and regeneration. Nature 2008, 453, 314–321. [Google Scholar] [CrossRef]
  27. Gramma, L.S.D.; Marques, F.M.; Vittorazzi, C.; de Andrade, T.A.; Frade, M.A.; de Andrade, T.U.; Endringer, D.C.; Scherer, R.; Fronza, M. Struthanthus vulgaris ointment prevents an over expression of inflammatory response and accelerates the cutaneous wound healing. J. Ethnopharmacol. 2016, 190, 319–327. [Google Scholar] [CrossRef]
  28. Arunachalam, K.; Parimelazhagan, T. Anti-inflammatory, wound healing and in-vivo antioxidant properties of the leaves of Ficus amplissima Smith. J. Ethnopharmacol. 2013, 145, 139–145. [Google Scholar] [CrossRef]
  29. Winterbourn, C.C.; Hawkins, R.E.; Brian, M.; Carrell, R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 1975, 85, 337–341. [Google Scholar]
  30. Yoshikawa, T.; Naito, Y.; Kishi, A.; Tomii, T.; Kaneko, T.; Iinuma, S.; Ichikawa, H.; Yasuda, M.; Takahashi, S.; Kondo, M. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993, 34, 732–737. [Google Scholar] [CrossRef] [Green Version]
  31. Carlberg, I.; Mannervick, B. Glutathione reductase. Methods Enzym. 1985, 113, 484–499. [Google Scholar] [CrossRef]
  32. Faure, P.; Lafond, J.L. Measurement of plasma sulfhydryl and carbonyl groups as a possible indicator of protein oxidation. In Analysis of Free Radicals in Biological Systems, 1st ed.; Birkhäauser: Basel, Switzerland, 1995; pp. 237–248. [Google Scholar]
  33. Krawisz, J.E.; Sharon, P.; Stenson, W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87, 1344–1350. [Google Scholar] [CrossRef]
  34. Nóbrega, R.H.; Greebe, C.D.; van de Kant, H.; Bogerd, J.; de Franca, L.R.; Schulz, R.W. Spermatogonial stem cell niche and spermatogonial stem cell transplantation in zebrafish. PLoS ONE 2010, 5, e12808. [Google Scholar] [CrossRef] [Green Version]
  35. Vischer, H.F.; Teves, A.C.; Ackermans, J.C.; van Dijk, W.; Schulz, R.W.; Bogerd, J. Cloning and spatiotemporal expression of the follicle-stimulating hormone beta subunit complementary DNA in the African catfish (Clarias gariepinus). Biol. Reprod. 2003, 68, 1324–1332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Ramanathan, G.; Muthukumar, T.; Tirichurapalli Sivagnanam, U. In vivo efficiency of the collagen coated nanofibrous scaffold and their effect on growth factors and pro-inflammatory cytokines in wound healing. Eur. J. Pharm. 2017, 814, 45–55. [Google Scholar] [CrossRef] [PubMed]
  37. Soriano, J.L.; Calpena, A.C.; Rodríguez-Lagunas, M.J.; Domènech, Ò.; Bozal-de Febrer, N.; Garduño-Ramírez, M.L.; Clares, B. Endogenous antioxidant cocktail loaded hydrogel for topical wound healing of burns. Pharmaceutics 2020, 13, 8. [Google Scholar] [CrossRef] [PubMed]
  38. Kozyreva, T.V.; Khramova, G.M.; Voronova, I.P.; Evtushenko, A.A. The influence of cooling and TRPM8 ion channel activation on the level of pro-inflammatory cytokines in normotensive and hypertensive rats. J. Biol. 2016, 61, 119–124. [Google Scholar] [CrossRef] [PubMed]
  39. Modarresi, M.; Farahpour, M.R.; Baradaran, B. Topical application of Mentha piperita essential oil accelerates wound healing in infected mice model. Inflammopharmacology 2019, 27, 531–537. [Google Scholar] [CrossRef] [PubMed]
  40. Babamohamadi, H.; Ansari, Z.; Nobahar, M.; Mirmohammadkhani, M. The effects of peppermint gel on prevention of pressure injury in hospitalized patients with head trauma in neurosurgical ICU: A double-blind randomized controlled trial. Complement. Med. 2019, 47, 102223. [Google Scholar] [CrossRef]
  41. Ud-Din, S.; Wilgus, T.A.; McGeorge, D.D.; Bayat, A. Pre-emptive priming of human skin improves cutaneous scarring and is superior to immediate and delayed topical anti-scarring treatment post-wounding: A double-blind randomised placebo-controlled clinical trial. Pharmaceutics 2021, 13, 510. [Google Scholar] [CrossRef]
  42. Deng, L.; Du, C.; Song, P.; Chen, T.; Rui, S.; Armstrong, D.G.; Deng, W. The role of oxidative stress and antioxidants in diabetic wound healing. Oxid. Med. Cell Longev. 2021, 2021, 8852759. [Google Scholar] [CrossRef]
  43. Abdel-Lateff, A.; Abdel-Naim, A.B.; Alarif, W.M.; Algandaby, M.M.; Alburae, N.A.; Alghamdi, A.M.; Nasrullah, M.Z.; Fahmy, U.A. Euryops arabicus promotes healing of excised wounds in rat skin: Emphasis on its collagen-enhancing, antioxidant, and anti-inflammatory activities. Oxid. Med. Cell Longev. 2021, 2021, 8891445. [Google Scholar] [CrossRef]
  44. Murthy, S.; Gautam, M.K.; Goel, S.; Purohit, V.; Sharma, H.; Goel, R.K. Evaluation of in vivo wound healing activity of Bacopa monniera on different wound model in rats. Biomed. Res. Int. 2013, 2013, 972028. [Google Scholar] [CrossRef] [Green Version]
  45. Lin, T.K.; Zhong, L.; Santiago, J.L. Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils. Int. J. Mol. Sci. 2017, 19, 70. [Google Scholar] [CrossRef] [Green Version]
  46. Al-Dhuayan, I.; Kotb, E.; Alqosaibi, A.; Mahmoud, A. Histological studies on a newly isolated Bacillus subtilis D10 protease in the debridement of burn wound eschars using mouse model. Pharmaceutics 2021, 13, 923. [Google Scholar] [CrossRef]
  47. Dorjsembe, B.; Lee, H.J.; Kim, M.; Dulamjav, B.; Jigjid, T.; Nho, C.W. Achillea asiatica extract and its active compounds induce cutaneous wound healing. J. Ethnopharmacol. 2017, 206, 306–314. [Google Scholar] [CrossRef]
  48. Bastaki, S.M.; Adeghate, E.; Amir, N.; Ojha, S.; Oz, M. Menthol inhibits oxidative stress and inflammation in acetic acid-induced colitis in rat colonic mucosa. Am. J. Transl. Res. 2018, 10, 4210–4222. [Google Scholar] [PubMed]
  49. Wang, Q.; Yang, Y.; Chen, K.L.; Tang, B.; Peng, K.; Wang, Z.; Yang, P.; Yang, D.; Yang, Y. Dietary menthol attenuates inflammation and cardiac remodeling after myocardial infarction via the Transient Receptor Potential Melastatin 8. Am. J. Hypertens 2019, 33, 223–233. [Google Scholar] [CrossRef]
  50. Pastar, I.; Stojadinovic, O.; Yin, N.C.; Ramirez, H.; Nusbaum, A.G.; Sawaya, A.; Patel, S.B.; Khalid, L.; Isseroff, R.R.; Tomic-Canic, M. Epithelialization in wound healing: A comprehensive review. Adv. Wound Care 2014, 3, 445–464. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Pinto, P.I.S.; Estevão, M.D.; Redruello, B.; Socorro, S.M.; Canário, A.V.M.; Power, D.M. Immunohistochemical detection of estrogen receptors in fish scales. Gen. Comp. Endocrinol. 2009, 160, 19–29. [Google Scholar] [CrossRef] [PubMed]
  52. Kubo, H.; Hayashi, T.; Ago, K.; Ago, M.; Kanekura, T.; Ogata, M. Temporal expression of wound healing-related genes in skin burn injury. Leg Med. 2014, 16, 8–13. [Google Scholar] [CrossRef]
  53. Tatiya-Aphiradee, N.; Chatuphonprasert, W.; Jarukamjorn, K. Anti-inflammatory effect of Garcinia mangostana Linn. pericarp extract in methicillin-resistant Staphylococcus aureus-induced superficial skin infection in mice. Biomed. Pharm. 2019, 111, 705–713. [Google Scholar] [CrossRef] [PubMed]
  54. Luo, P.; Li, X.; Ye, Y.; Shu, X.; Gong, J.; Wang, J. Castanea mollissima shell prevents an over expression of inflammatory response and accelerates the dermal wound healing. J. Ethnopharmacol. 2018, 220, 9–15. [Google Scholar] [CrossRef] [PubMed]
  55. Ram, M.; Singh, V.; Kumawat, S.; Kumar, D.; Lingaraju, M.C.; Uttam Singh, T.; Rahal, A.; Tandan, S.K.; Kumar, D. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. Eur. J. Pharm. 2015, 764, 9–21. [Google Scholar] [CrossRef]
  56. Kaisang, L.; Siyu, W.; Lijun, F.; Daoyan, P.; Xian, C.J.; Jie, S. Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing. J. Surg. Res. 2017, 217, 63–74. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 13 01902 g001 550
Figure 1. Percentage of skin wound contraction at the back of rats after 3, 7, or 14 days of treatment with vehicle, collagenase cream, ME.025, ME0.5, or ME1.0. ANOVA, Dunnett’s test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 1. Percentage of skin wound contraction at the back of rats after 3, 7, or 14 days of treatment with vehicle, collagenase cream, ME.025, ME0.5, or ME1.0. ANOVA, Dunnett’s test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Pharmaceutics 13 01902 g001
Pharmaceutics 13 01902 g002 550
Figure 2. Skin wounds at the moment they were performed and after 3, 7, or 14 days of treatment with vehicle, collagenase cream, ME.025, ME0.5, or ME1.0.
Figure 2. Skin wounds at the moment they were performed and after 3, 7, or 14 days of treatment with vehicle, collagenase cream, ME.025, ME0.5, or ME1.0.
Pharmaceutics 13 01902 g002
Pharmaceutics 13 01902 g003 550
Figure 3. Representative histological sections of skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5 (HE staining). Scale bar: 200 µm.
Figure 3. Representative histological sections of skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5 (HE staining). Scale bar: 200 µm.
Pharmaceutics 13 01902 g003
Pharmaceutics 13 01902 g004 550
Figure 4. Levels of Il-1β (A), TNF-α (B), IL-10 (C), and Ki-67 (D) mRNA expression in skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5. ANOVA, Dunnett’s test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 4. Levels of Il-1β (A), TNF-α (B), IL-10 (C), and Ki-67 (D) mRNA expression in skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5. ANOVA, Dunnett’s test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Pharmaceutics 13 01902 g004
Table
Table 1. Specifications of primers used in RT-qPCR.
Table 1. Specifications of primers used in RT-qPCR.
GeneSize (bp)Sequence 5′–3′MTNCBI Reference Sequence
Il-1β93FW: AGGCTTCCTTGTGCAAGTGT60 °CNM_031512.2
RV: AGGTCATTCTCCTCACTGTCG
Il-692FW: TCATTCTGTCTCGAGCCCAC60 °CNM_012589.2
RV: CTCCGCAAGAGACTTCCAGC
Il-1095FW: GACGCTGTCATCGATTTCTCC60 °CNM_012854.2
RV: GCTCCAAGACAAAGGTGTCTAC
Tnf-α100FW: ATGGGCTCCCTCTCATCAGT60 °CNM_012675.3
RV: TGGTTTGCTACGACGTGGG
Ki-67100FW: GGGTTTCCAGACACCAGACC60 °CNM_001271366.1
RV: CCAGGAAGACCAGTTAGAACC
Ef-1α91FW: CTTTGGACTGCATTCTGCCG60 °CNM_175838.1
RV: GTGCCAATGCCGCCAATTTT
Bp: base pairs, MT: melting temperature, FW: forward, RV: reverse.
Table
Table 2. Quantity of GSH and activities of GR, GPx, SOD, and MPO after 3, 7 or 14 days of wound treatment with vehicle, collagenase cream or ME0.5.
Table 2. Quantity of GSH and activities of GR, GPx, SOD, and MPO after 3, 7 or 14 days of wound treatment with vehicle, collagenase cream or ME0.5.
PeriodTreatmentGSHGRGPxSODMPO
3 daysVehicle3.29 ± 0.2857.61 ± 2.8926.50 ± 4.1733.21 ± 2.070.23 ± 0.03
Collagenase3.72 ± 0.4660.12 ± 3.5222.99 ± 3.2031.17 ± 1.870.35 ± 0.05
ME0.52.46 ± 0.2258.20 ± 0.8824.27 ± 2.8732.13 ± 3.740.39 ± 0.01
7 daysVehicle3.43 ± 0.3531.93 ± 4.1419.10 ± 3.0336.42 ± 2.630.12 ± 0.01
Collagenase6.01 ± 0.9334.28 ± 3.6621.76 ± 2.8941.63 ± 4.320.10 ± 0.00
ME0.511.39 ± 0.92 ***48.83 ± 4.12 *31.73 ± 2.27 *50.86 ± 5.82 *0.11 ± 0.01
14 daysVehicle13.65 ± 2.1896.34 ± 4.0162.88 ± 3.5731.31 ± 2.540.47 ± 0.09
Collagenase12.03 ± 0.7597.00 ± 4.5558.20 ± 2.8634.48 ± 1.460.30 ± 0.02
ME0.510.82 ± 1.0082.89 ± 2.5753.31 ± 1.8027.35 ± 0.450.24 ± 0.02 *
GSH level: nmol/mg of protein; GPx and GR: nmol/min/mg of protein; SOD and MPO: U/mg of protein. ANOVA, Dunnett’s test, * p < 0.05; *** p < 0.001.
Table
Table 3. Levels of IL-1β, IL-6, TNF-α, and IL-10 in skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5.
Table 3. Levels of IL-1β, IL-6, TNF-α, and IL-10 in skin wounds after 3, 7, or 14 days of treatment with vehicle, collagenase cream, or ME0.5.
PeriodTreatmentIL-1βIL-6TNF-αIL-10
3 daysVehicle1238.00 ± 137.902083.00 ± 219.00205.50 ± 34.11203.60 ± 66.43
Collagenase1176.00 ± 186.601730.00 ± 264.30202.70 ± 64.39181.70 ± 51.34
ME0.51177.00 ± 226.501505.00 ± 308.10120.10 ± 27.55397.60 ± 158.90
7 daysVehicle807.20 ± 165.801893.00 ± 566.8080.35 ± 27.41144.90 ± 35.17
Collagenase579.50 ± 104.80820.80 ± 218.70 *45.33 ± 13.75457.50 ± 149.70
ME0.5266.60 ± 68.05 *570.10 ± 98.06 **21.19 ± 4.03 *262.30 ± 78.13
14 daysVehicle2230.00 ± 254.70 1653.00 ± 177.30138.30 ± 40.96217.10 ± 70.60
Collagenase1369.00 ± 207.70 *1113.00 ± 149.0030.52 ± 8.73 **645.50 ± 156.80
ME0.5937.40 ± 142.20 ***831.70 ± 173.30 **31.58 ± 10.02 **1128.00 ± 161.80 **
The results were expressed as pg/mg of protein. ANOVA, Dunnett’s test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rozza, A.L.; Beserra, F.P.; Vieira, A.J.; Oliveira de Souza, E.; Hussni, C.A.; Martinez, E.R.M.; Nóbrega, R.H.; Pellizzon, C.H. The Use of Menthol in Skin Wound Healing—Anti-Inflammatory Potential, Antioxidant Defense System Stimulation and Increased Epithelialization. Pharmaceutics 2021, 13, 1902. https://doi.org/10.3390/pharmaceutics13111902

AMA Style

Rozza AL, Beserra FP, Vieira AJ, Oliveira de Souza E, Hussni CA, Martinez ERM, Nóbrega RH, Pellizzon CH. The Use of Menthol in Skin Wound Healing—Anti-Inflammatory Potential, Antioxidant Defense System Stimulation and Increased Epithelialization. Pharmaceutics. 2021; 13(11):1902. https://doi.org/10.3390/pharmaceutics13111902

Chicago/Turabian Style

Rozza, Ariane Leite, Fernando Pereira Beserra, Ana Júlia Vieira, Eduardo Oliveira de Souza, Carlos Alberto Hussni, Emanuel Ricardo Monteiro Martinez, Rafael Henrique Nóbrega, and Cláudia Helena Pellizzon. 2021. "The Use of Menthol in Skin Wound Healing—Anti-Inflammatory Potential, Antioxidant Defense System Stimulation and Increased Epithelialization" Pharmaceutics 13, no. 11: 1902. https://doi.org/10.3390/pharmaceutics13111902

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop